Aktuellt
SENASTE
Europe's favourable weather and rising airline passenger volumes indicate stable Q2 demand across the HoReCa-industry, benefiting both Duni and BioPak. However, tough comps and market pricing pressures present challenges. Despite this, Duni's pre-pandemic volume recovery and BioPak's lean operations promise strong cash flow and growth opportunities. We reiterate our DCF-based mid-point valuation of SEK 160 per share
LÄS MER
